Patent Application: Synergistic Stimulation for Cystic Fibrosis Mucus Obstruction
Summary
The USPTO has published a new patent application (US20260083698A1) detailing methods for treating mucus obstruction in cystic fibrosis and other disorders. The application, filed on September 19, 2023, describes a combination therapy involving a b-adrenergic agonist or adenylate cyclase activator with a cholinergic agonist.
What changed
This document is a patent application (US20260083698A1) filed with the USPTO on September 19, 2023. It describes a novel therapeutic method for treating muco-obstructive disorders, specifically cystic fibrosis, by administering a combination of a b-adrenergic agonist or adenylate cyclase activator and a cholinergic agonist. The application details the synergistic stimulation of mucociliary clearance as the mechanism of action.
While patent applications are not regulations, they indicate potential future developments in pharmaceutical treatments. Companies involved in drug development for respiratory diseases, particularly cystic fibrosis, should be aware of this patented technology. Compliance officers in the pharmaceutical sector should monitor the progression of this patent and similar research, as it may influence future product development and regulatory submissions in the area of muco-obstructive disorder treatments.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Synergistic Stimulation of Mucociliary Clearance to Treat Mucus Obstruction in Cystic Fibrosis and Other Muco-Obstructive Disorders
Application US20260083698A1 Kind: A1 Mar 26, 2026
Inventors
Jeffrey J. Wine, Nam Soo Joo, Carlos E. Milla
Abstract
The present disclosure provides methods of treating an individual for a muco-obstructive, the methods including: administering to the individual a b-adrenergic agonist or an adenylate cyclase activator, in combination with a cholinergic agonist to treat the individual for the muco-obstructive disorder.
CPC Classifications
A61K 31/352 A61K 31/27 A61P 11/12
Filing Date
2023-09-19
Application No.
19110980
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.